All lobbying filings
THE MCMANUS GROUP
THE MCMANUS GROUP filed a Q1 report for ACESSO BIOLOGICS on April 21, 2025, reporting $30,000 in lobbying income.
Lobbying for ACESSO BIOLOGICS · Biologics Company
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Income
$30,000
What the client paid this registrant for the period.
Client based in
Nevada
Government bodies contacted
5
Lobbying activity
1
Issues related to coverage of Human Cell & Tissue products, including Local Coverage Determination L39764- Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers.